Latest filing published 24 Nov 2025 for ResMed Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +5.0%Entry US$69.57 · Close at T+365 US$73.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronald R. Taylor: trading record in brief
Ronald R. Taylor is a declared insider at 4 companies (board member); the most frequent names are ResMed Inc, Red Lion Hotels Corp and Watson Pharmaceuticals Inc. We count 87 filings; the first trade dates from 5 May 2006 and the latest from 20 November 2025.
Both buying and selling appear: 1 purchase worth €152k, against 14 sales worth €12.6M. On balance, insiders were net sellers of €12.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 63 share grants and 8 option exercises.
Most recently, on 24 November 2025, the filings show a share grant in ResMed Inc. The last insider purchase was made public on 17 August 2016, 3,735 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ronald R. Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,073 shares0ResMed Common StockSEC:0000943819-25-000172:0
- 1,083 shares0ResMed Common StockSEC:0001127602-24-027906:0
- 1,768 shares0ResMed Common StockSEC:0001127602-23-028038:0
- 1,122 shares0ResMed Common StockSEC:0001127602-22-026078:0
- 956 shares0ResMed Common StockSEC:0000943819-21-000033:0
- 4,000 shares@ US$200.1420.9% of flowResMed Common StockSEC:0001127602-21-006887:0
- 1,187 shares0ResMed Common StockSEC:0001127602-20-029774:0
- 1,727 shares0ResMed Common StockSEC:0001127602-19-033684:0
- 4,429 shares@ US$136.34100.0% of flowResMed Common StockSEC:0001127602-19-027155:0
- 2,533 shares0ResMed Common StockSEC:0001567619-18-006567:0
- 4,885 shares@ US$99.7115.8% of flowResMed Common StockSEC:0001140361-18-003152:0
- 2,991 shares0ResMed Common StockSEC:0001140361-17-043348:0
- 1,223 shares@ US$245.2539.8% of flowOrdinary Shares, par value $0.0001SEC:0001179110-17-006731:1
- 668 shares@ US$243.7621.8% of flowOrdinary Shares, par value $0.0001SEC:0001179110-17-006731:0
- 4,429 shares0ResMed Common StockSEC:0001140361-16-087151:0
- 23,102 shares@ US$69.2556.5% of flowResMed Common StockSEC:0001140361-16-077083:0
- 2,487 shares@ US$69.136.1% of flowResMed Common StockSEC:0001140361-16-077083:1Canonical exit: 15 Nov 2016 (T+90)
- 201 shares@ US$248.316.6% of flowOrdinary Shares, par value $0.0001SEC:0001179110-16-028449:0
- 1,188 shares@ US$210.3431.9% of flowOrdinary Shares, par value $0.0001SEC:0001179110-16-024195:0
- 4,360 shares0ResMed Common StockSEC:0001140361-15-042669:0
- 36,000 shares@ US$15.52ResMed Common StockSEC:0001140361-15-003061:0
- 36,000 shares@ US$66.98ResMed Common StockSEC:0001140361-15-003061:1
- 4,885 shares0ResMed Common StockSEC:0001140361-14-043139:0
- 1,142 shares@ US$197.05Ordinary Shares, $0.0001SEC:0001179110-14-008310:0
- 2,921 sharesCommon StockSEC:0001209191-14-002284:0
25 of 82 declarations
